LIBRETTO-121

E1549332 UNEXPLORED

LIBRETTO-121 is a clinical trial evaluating the investigational RET inhibitor LOXO-292 (selpercatinib) in patients with cancers driven by RET gene alterations.

All labels observed (2)

Label Occurrences
LIBRETTO-121 canonical 1
LIBRETTO-321 1

How this entity was disambiguated

Referenced by (2)

Full triples — surface form annotated when it differs from this entity's canonical label.

LOXO-292 hasClinicalTrialIdentifier LIBRETTO-121
LOXO-292 hasClinicalTrialIdentifier LIBRETTO-321
linked to: LIBRETTO-121